Broadfin Capital as of Dec. 31, 2018
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 47 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 23.0 | $175M | 700k | 249.92 | |
| Tesaro | 7.5 | $57M | 767k | 74.25 | |
| Iovance Biotherapeutics (IOVA) | 6.9 | $53M | 6.0M | 8.85 | |
| SPDR S&P Biotech (XBI) | 6.6 | $50M | 700k | 71.75 | |
| Nevro (NVRO) | 5.3 | $41M | 1.0M | 38.89 | |
| Aratana Therapeutics | 3.3 | $25M | 4.1M | 6.13 | |
| Global Blood Therapeutics In | 3.2 | $24M | 591k | 41.05 | |
| Retrophin | 3.0 | $23M | 1.0M | 22.63 | |
| Adamas Pharmaceuticals | 2.9 | $22M | 2.6M | 8.54 | |
| Dex (DXCM) | 2.8 | $22M | 180k | 119.80 | |
| Zogenix | 2.6 | $20M | 536k | 36.46 | |
| La Jolla Pharmaceuticl Com Par | 2.4 | $18M | 1.9M | 9.43 | |
| BioDelivery Sciences International | 2.1 | $16M | 4.4M | 3.70 | |
| Recro Pharma (SCTL) | 1.9 | $15M | 2.0M | 7.10 | |
| Aclaris Therapeutics (ACRS) | 1.8 | $14M | 1.9M | 7.39 | |
| Strongbridge Bioph shs usd | 1.7 | $13M | 2.8M | 4.48 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.6 | $12M | 6.3M | 1.92 | |
| Incyte Corporation (INCY) | 1.5 | $12M | 183k | 63.59 | |
| Nanostring Technologies (NSTGQ) | 1.4 | $11M | 721k | 14.83 | |
| Quotient | 1.4 | $10M | 1.7M | 6.12 | |
| Adma Biologics (ADMA) | 1.3 | $10M | 4.2M | 2.39 | |
| Antares Pharma | 1.2 | $9.4M | 3.4M | 2.72 | |
| Integra LifeSciences Holdings (IART) | 1.2 | $8.9M | 197k | 45.10 | |
| Mirati Therapeutics | 1.1 | $8.5M | 200k | 42.42 | |
| Intersect Ent | 1.1 | $8.1M | 288k | 28.18 | |
| Flamel Technologies Sa (AVDL) | 1.1 | $8.0M | 3.1M | 2.58 | |
| Sierra Oncology | 0.8 | $6.4M | 4.9M | 1.32 | |
| Alexion Pharmaceuticals | 0.8 | $5.7M | 59k | 97.36 | |
| Strata Skin Sciences (SSKN) | 0.7 | $5.6M | 2.2M | 2.60 | |
| Viewray (VRAYQ) | 0.7 | $5.3M | 867k | 6.07 | |
| Sol Gel Technologies (SLGL) | 0.7 | $5.1M | 848k | 6.02 | |
| Biohaven Pharmaceutical Holding | 0.6 | $4.8M | 129k | 36.98 | |
| Livanova Plc Ord (LIVN) | 0.6 | $4.7M | 51k | 91.47 | |
| Optinose (OPTN) | 0.6 | $4.4M | 711k | 6.20 | |
| Neos Therapeutics | 0.6 | $4.3M | 2.6M | 1.65 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.5 | $4.1M | 529k | 7.75 | |
| Teligent | 0.5 | $3.9M | 2.8M | 1.37 | |
| Tandem Diabetes Care (TNDM) | 0.4 | $3.4M | 89k | 37.97 | |
| Vericel (VCEL) | 0.4 | $3.3M | 190k | 17.40 | |
| Heron Therapeutics (HRTX) | 0.4 | $3.1M | 119k | 25.94 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $2.8M | 143k | 19.75 | |
| Dova Pharmaceuticals | 0.3 | $2.7M | 352k | 7.58 | |
| Kala Pharmaceuticals | 0.2 | $1.7M | 339k | 4.89 | |
| Eiger Biopharmaceuticals | 0.2 | $1.5M | 143k | 10.16 | |
| Idera Pharmaceuticals | 0.2 | $1.3M | 487k | 2.77 | |
| Alphatec Holdings (ATEC) | 0.1 | $1.0M | 450k | 2.29 | |
| Noveliontherapeuti.. | 0.1 | $1.0M | 1.2M | 0.84 |
